Status:
COMPLETED
Acute Effects of Cannabigerol
Lead Sponsor:
Washington State University
Conditions:
Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition
Eligibility:
All Genders
21+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to examine the effects of hemp-derived cannabigerol (CBG) on anxiety, stress, mood, and cognition. Further, the severity of various side effects of CBG (sleepiness, dry mo...
Detailed Description
Recruitment: Prospective participants aged 21+ who have experience using cannabis-based products will be recruited from our previous survey of CBG users, from a CBG distributor in Washington (WA) stat...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- 21+ years of age
- reside in Washington state
- own a smartphone
- have access to a private environment where they can access a computer with a webcam connected to a high-quality and stable internet
- speak fluent English
- be literate
- have experience using cannabis-based products without serious adverse reactions
- Exclusion Criteria
- serious psychiatric disorders (e.g., psychotic disorder, bipolar disorder)
- neurological and other serious medical conditions including head injury
- pregnancy, or breastfeeding
- use of illicit substances in past 2 months
Exclusion
Key Trial Info
Start Date :
March 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2023
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT05257044
Start Date
March 24 2022
End Date
November 28 2023
Last Update
April 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington State University
Pullman, Washington, United States, 99164